KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 92 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $975,222 | -75.7% | 108,358 | -81.8% | 0.01% | -77.8% |
| Q4 2022 | $4,014,156 | -63.3% | 593,810 | -21.1% | 0.05% | -64.7% |
| Q3 2022 | $10,924,000 | +2.1% | 752,881 | -30.7% | 0.15% | -7.3% |
| Q2 2022 | $10,695,000 | +46.0% | 1,086,883 | +118.7% | 0.16% | +38.7% |
| Q1 2022 | $7,326,000 | +299.0% | 497,014 | +258.2% | 0.12% | +357.7% |
| Q4 2021 | $1,836,000 | -18.7% | 138,738 | +7.3% | 0.03% | -29.7% |
| Q3 2021 | $2,257,000 | -7.4% | 129,351 | +27.2% | 0.04% | -17.8% |
| Q2 2021 | $2,437,000 | -57.7% | 101,706 | -54.6% | 0.04% | -64.8% |
| Q1 2021 | $5,756,000 | – | 224,059 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |